XML 19 R8.htm IDEA: XBRL DOCUMENT
v3.20.2

CONDENSED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) | 9 Months Ended
--- | ---
Sep. 30, 2020 | Sep. 30, 2019
Stock issuance expenses | $ 633,807 | $ 97,260
Series C Convertible Preferred Stock |  |
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment |  | $ 235,640
Series D Convertible Preferred Stock |  |
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment | $ 488,270 |

X
- Definition Discount of Issuance of Common Stock, Preferred Stock and Warrants for Clinical Trial Funding Commitment + References No definition available. + Details
Name: | crdf_DiscountofIssuanceofCommonStockPreferredStockandWarrantsforClinicalTrialFundingCommitment
Namespace Prefix: | crdf_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=crdf_SeriesCConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=crdf_SeriesDConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |